Literature DB >> 11156529

BRCA1 and cell signaling.

Q Wang1, H Zhang, R Fishel, M I Greene.   

Abstract

The breast cancer and ovarian cancer susceptibility gene BRCA1 encodes a nucleoprotein whose mutations or aberrant expression is associated with both inherited and sporadic cancers. Studies over the last 6 years have suggested that BRCA1 may function as a scaffold in the assembly of a multi-protein complex, which plays a role in gene transcription, DNA damage repair, and transcription-coupled DNA damage repair. In this review, we discuss the implications drawn from the studies of BRCA1-interacting proteins and the cellular signaling pathways that may be involved in controlling the functions of BRCA1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11156529     DOI: 10.1038/sj.onc.1203974

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.

Authors:  Eugene S Kandel; Jennifer Skeen; Nathan Majewski; Antonio Di Cristofano; Pier Paolo Pandolfi; Claudine S Feliciano; Andrei Gartel; Nissim Hay
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

2.  Escaping the cut by restriction enzymes through single-strand self-annealing of host-edited 12-bp and longer synthetic palindromes.

Authors:  Fernando Castro-Chavez
Journal:  DNA Cell Biol       Date:  2011-09-06       Impact factor: 3.311

3.  BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly.

Authors:  Shiaw-Yih Lin; Rekha Rai; Kaiyi Li; Zhi-Xiang Xu; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

4.  E2F regulates FASCIATA1, a chromatin assembly gene whose loss switches on the endocycle and activates gene expression by changing the epigenetic status.

Authors:  Elena Ramirez-Parra; Crisanto Gutierrez
Journal:  Plant Physiol       Date:  2007-03-09       Impact factor: 8.340

5.  Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int Urol Nephrol       Date:  2008-02-21       Impact factor: 2.370

6.  BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study.

Authors:  Luisel J Ricks-Santi; Jing Nie; Catalin Marian; Heather M Ochs-Balcom; Maurizio Trevisan; Stephen B Edge; Yasmine Kanaan; Jo L Freudenheim; Peter G Shields
Journal:  Genet Epidemiol       Date:  2013-05-14       Impact factor: 2.135

7.  Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.

Authors:  Maria Henningson; Erika Bågeman; Therese Sandberg; Ake Borg; Håkan Olsson; Helena Jernström
Journal:  Fam Cancer       Date:  2007-05-05       Impact factor: 2.375

8.  Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.

Authors:  Hagit Schayek; Kathy Haugk; Shihua Sun; Lawrence D True; Stephen R Plymate; Haim Werner
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

9.  [Therapy selection in patients with advanced bladder cancer. Is molecular biology helpful?].

Authors:  K Junker; A Hartmann; M Stöckle
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

10.  BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells.

Authors:  Akiko Horiuchi; Cuiju Wang; Norihiko Kikuchi; Ryosuke Osada; Toshio Nikaido; Ikuo Konishi
Journal:  Biomark Insights       Date:  2007-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.